C. Bertazzoli

Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis.

N. Lydon, M. Di Nicola, C. Gambacorti-Passerini, 1997, Blood cells, molecules & diseases.

In vitro transcription and translation inhibition by anti-promyelocytic leukemia (PML)/retinoic acid receptor alpha and anti-PML peptide nucleic acid.

P. Nielsen, C. Gambacorti-Passerini, F. Grignani, 1996, Blood.

Mapping of HLA class I binding motifs in forty-four fusion proteins involved in human cancers.

G. Parmiani, C. Gambacorti-Passerini, D. Schendel, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Differential recognition of a BCR/ABL peptide by lymphocytes from normal donors and chronic myeloid leukemia patients.

C. Lombardo, C. Gambacorti-Passerini, F. Ravagnani, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

nucleic acid leukemia (PML)/retinoic acid receptor alpha and anti-PML peptide In vitro transcription and translation inhibition by anti-promyelocytic

C. Gambacorti-Passerini, F. Grignani, E. Marchesi, 2011 .

Lack of T-cell-mediated recognition of the fusion region of the pml/RAR-alpha hybrid protein by lymphocytes of acute promyelocytic leukemia patients.

G. Parmiani, C. Gambacorti-Passerini, K. Blaser, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

ALK as a novel lymphoma-associated tumor antigen: identification of 2 HLA-A2.1-restricted CD8+ T-cell epitopes.

F. Lemonnier, B. Gallo, C. Gambacorti-Passerini, 2002, Blood.